BridgeMD
New treatment option for Stroke
Official title Comparative Effects of Task-Oriented Training and Hand-Arm Bimanual Intensive in Post-Stroke Patients
ClinicalTrials.gov ID: NCT07724925
What this study is testing
- What it's testing
- Stroke is a rapidly developing clinical signs of focal (or global) disturbance of cerebral function, lasting more than 24 hours or leading to death, with no apparent cause other than a vascular origin. Among various rehabilitation strategies, Task-oriented training of low to moderate intensity and Hand-Arm bimanual intensive therapy have shown their promising results in stroke rehabilitation.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 70
You may be able to join if
- Age 45-70
- Gender (both male and female)
- Pre diagnosed First-time stroke patients (ischemic or hemorrhagic)
- Time since stroke: ≥3 months
- Mild to moderate upper limb impairment (ABILHAND Questionnaire: Less than 50% of items rated as "impossible.")
You likely can't join if
- Severe spasticity (Modified Ashworth Scale score ≥ 3) or contractures
- Other neurological conditions (Alzheimer's disease, Parkinson and dementia)
- Unstable medical conditions (diabetes and hypertension) that may interfere with participation
- Participation in any other structured upper limb rehabilitation or experimental therapy within the past 3 months
See the full eligibility criteria
- Age 45-70
- Gender (both male and female)
- Pre diagnosed First-time stroke patients (ischemic or hemorrhagic)
- Time since stroke: ≥3 months
- Mild to moderate upper limb impairment (ABILHAND Questionnaire: Less than 50% of items rated as "impossible.")
- Moderate functional independence in basic activities (Barthel Index score ≥ 60)
- Ability to follow commands (MMSE \> 24 or equivalent cognitive screening)
- Severe spasticity (Modified Ashworth Scale score ≥ 3) or contractures
- Other neurological conditions (Alzheimer's disease, Parkinson and dementia)
- Unstable medical conditions (diabetes and hypertension) that may interfere with participation
- Participation in any other structured upper limb rehabilitation or experimental therapy within the past 3 months
The study team makes the final eligibility decision.
Where it's taking place
- Nankana Sahib, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nankana Sahib, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.